Growth Metrics

Idexx Laboratories (IDXX) Total Current Liabilities (2016 - 2026)

Idexx Laboratories has reported Total Current Liabilities over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 7.58% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 7.58%, while the annual FY2025 figure was $1.1 billion, 7.58% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $1.1 billion at Idexx Laboratories, down from $1.3 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $1.3 billion in Q3 2025 and troughed at $620.7 million in Q1 2021.
  • A 5-year average of $1.0 billion and a median of $1.0 billion in 2023 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: dropped 26.66% in 2021 and later surged 87.73% in 2022.
  • Year by year, Total Current Liabilities stood at $763.6 million in 2021, then soared by 61.84% to $1.2 billion in 2022, then decreased by 23.0% to $951.5 million in 2023, then increased by 12.23% to $1.1 billion in 2024, then grew by 7.58% to $1.1 billion in 2025.
  • Business Quant data shows Total Current Liabilities for IDXX at $1.1 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.2 billion in Q2 2025.